This study is a prospective phase II trial, designed to assess the efficacy and feasibility of adjuvant treatment deintensification guided by ctHPVDNA levels f…

Squamous Cell Carcinoma of OropharynxHPV Positive CancerThroat Cancer+1 more

~Estimated

~$10 – $6,250

Indiana UniversityNCT06915038

Observational

A Phase II Study of Treatment De-Escalation for Favorable Prognosis, Stage I-II Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy

The current standard treatment option for Human Papillomavirus (HPV) or p16-positive oropharyngeal cancer is full-dose radiation combined with chemotherapy. Re…

Oropharyngeal CancersHPVTonsil Cancer+1 more

~Estimated

~$10 – $6,250

Georgetown UniversityNCT06902623